NEUROONE MEDICAL TECHNOLOGIES Corp 8-K — AI Bull & Bear Analysis

NeuroOne Medical Technologies has issued a non-reliance notice for its Q1 2026 financial statements, citing accounting errors in revenue recognition that led to an estimated $529 thousand overstatement of revenue. While the company maintains that no intentional misconduct occurred, the need to restate the 10-Q and amend the Management’s Discussion and Analysis highlights a significant gap in internal controls regarding customer purchase orders. The market impact will likely depend on whether investors view this as a transparent cleanup of a minor error or a red flag indicating systemic instability in the company's financial reporting infrastructure.